Sarcoma, Clear Cell
Information
- Disease name
- Sarcoma, Clear Cell
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00258687 | Completed | Phase 1 | Vaccine Trial for Clear Cell Sarcoma, Pediatric Renal Cell Carcinoma, Alveolar Soft Part Sarcoma and Children With Stage IV Melanoma | January 2005 | December 2020 |
| NCT04593758 | Completed | Phase 1/Phase 2 | To Evaluate Maximally Tolerated Dose (MTD), Safety and Efficacy of CPI-613® (Devimistat) Plus Hydroxychloroquine in Patients With Relapsed or Refractory Clear Cell Sarcoma of Soft Tissue | September 1, 2021 | March 9, 2023 |
| NCT04274023 | Terminated | Phase 2 | Study on TSR-042 in Advanced Clear Cell Sarcoma | January 29, 2024 | January 29, 2024 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D018227